2021
DOI: 10.1038/s41587-021-01131-y
|View full text |Cite
|
Sign up to set email alerts
|

Single-cell immunology of SARS-CoV-2 infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
105
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 94 publications
(105 citation statements)
references
References 149 publications
0
105
0
Order By: Relevance
“…Exploring publicly available studies of either COVID-19 samples or healthy controls, we accumulated a collection of 14 studies with scRNA-seq measurements, representing a total of 3.46M cells from 639 individuals. Data from 11 of the studies was obtained from a recently published collection of standardized single-cell sequencing datasets 59 . We performed unsupervised atomic sketch integration, yielding a harmonized collection in which we annotated 30 cell states ( Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Exploring publicly available studies of either COVID-19 samples or healthy controls, we accumulated a collection of 14 studies with scRNA-seq measurements, representing a total of 3.46M cells from 639 individuals. Data from 11 of the studies was obtained from a recently published collection of standardized single-cell sequencing datasets 59 . We performed unsupervised atomic sketch integration, yielding a harmonized collection in which we annotated 30 cell states ( Fig.…”
Section: Resultsmentioning
confidence: 99%
“…These transitioning expanded T cell clones may represent unannotated SARS-CoV-2-specific T cells. Interferon- activated naïve T cells are a novel cell population and add to the growing recognition from single cell analyses that seemingly homogeneous cell populations, in this case the naïve T cell pool, may be more heterogeneous than previously recognized (Nguyen et al, 2018; Tian et al, 2021). Furthermore, this suggests that traditional nomenclature based on cell surface markers may be inadequate.…”
Section: Discussionmentioning
confidence: 99%
“…Another example of the power of rapidly dissecting immune signatures using single-cell multiomics technologies is observed in the rapid advancement of characterization of acute respiratory syndrome coronavirus (SARS-CoV-2). Throughout the COVID-19 pandemic outbreak, a large body of work was accumulated by the immunology community (Tian et al, 2022) to define the cells and pathways involved in SARS-CoV-2 pathology. Implementing cutting-edge genomic technologies will improve our ability to study this deadly pathogen, better understand the role of the immune system in the pathology and to design better therapies.…”
Section: Future: Consensual Systems-level Immunologymentioning
confidence: 99%